After both receiving FDA approval in UC, J&J and Eli Lilly are racing for their IL-23 inhibitors to get the green light in ...

Eli Lilly and Johnson & Johnson are seeking label expansions for Omvoh and Tremfya, respectively, in Crohn’s disease ...

It was how it would affect him socially.Being in his early 20s at the time, Kefford was focused on socialising and dating, ...

Complementary and alternative therapies for Crohn’s disease, like acupuncture and meditation, are useful approaches to managing symptoms in combination with a treatment plan.

Breastfeeding, child nutrition and exposure to secondhand tobacco smoke at an early age may play a role in the onset of ...

A new study explores the role of dysfunctioning mitochondria and a disrupted gut microbiome as a possible trigger of Crohn's ...

A new study in mice suggests that dysfunctional mitochondria may change the gut microbiome and thus drive Crohn's disease.

Eli Lilly announced that mirikizumab achieved long-term remission in Phase 3 IBD studies, showing promise for ulcerative ...

Crohn’s disease is a type of inflammatory bowel disease (IBD) that involves periods of remission and flares. Symptoms can ...

On Monday, Johnson & Johnson (NYSE:JNJ) announced results from the Phase 3 GRAVITI study of Tremfya (guselkumab) for Crohn’s ...

There is a strong connection between inflammatory bowel disease (IBD) and spondyloarthritis—a condition that causes pain and ...

Children who are exclusively breastfed for the first six months may subsequently have a lower risk of suffering from Crohn 's disease, according to Montreal researchers.